Site Name: Belgium-Wavre, Philadelphia Walnut Street, UK – London – New Oxford Street Posted Date: Feb 5 2025 Global Supply Chain Strategy Senior Director Vaccines The deadline for the job posting is the 26th of February in 2025 The Global Supply Chain (GSC) at GSK is accountable for ensuring the seamless, efficient, and timely production and distribution of our medicines and vaccines. This encompasses end-to-end operations, including manufacturing, quality control, logistics, and delivery to healthcare providers and patients worldwide; all powered by science, talent and technology so we can get ahead of disease together. With high standards of excellence and compliance, GSC ensures that GSK can reliably launch new products and meet the demand for its life-saving medications. We operate at impressive scale, with over 26,000 employees and 35 manufacturing sites, supporting 115 markets and producing over 2.3 billion packs of medicines and doses of vaccines, with an ambition to positively impact the health of more than 2.5 billion people by 2031. The GSC Strategy Senior Director position has the global accountability for developing and driving the execution of the manufacturing and supply strategy for a brand or a portfolio of vaccines. He/she acts as the single point of contact (SPOC) between Global Supply Chain (GSC), the Vaccines Development Teams and Vaccines Commercial Teams (VDT/VCT) which are the GSK teams accountable for the successful launch and continued marketing of GSK vaccines. He/she is the key architect of the manufacturing and supply network for each product. He/she leads, Strategy Leads who are responsible for overseeing and coordinating the end-to-end manufacturing and supply activities for the brand / portfolio of vaccines. Key responsibilities: Develop and drive the execution of the manufacturing and supply strategy for a brand or portfolio of vaccines in line with the business ambition and GSC’s network design strategy Define a manufacturing & supply strategy that supports the long-term brand ambition, is cost effective and maximizes the utilization of the existing GSK assets Maintain a 10-yr capacity plan that reflects the long-range demand forecast for each vaccine in the portfolio Assess future capacity requirements to support business growth, make recommendation on the strategy to achieve them (including investment/divestment and potential partnership responses) Develop key manufacturing intelligence on competitors Partner with Business Development on new opportunities Where applicable, prepare business cases for major capital investments Seek endorsement of the proposed strategy from the relevant GSK governance forums including the SCRB (Supply Chain Review Board) Translate the approved strategy in manageable projects and operational roadmaps and drive execution against objectives and deadlines Acts as the product leader in GSC and as a liaison between GSC, the Vaccines Development Teams and Vaccine Commercialization teams (VDT/VCT) - the accountable teams for the successful launch and continued marketing of GSK vaccines Act as the single point of contact in GSC for all other departments (Commercial, Regulatory Affairs, R&D, Finance, Medical, Business Development, Legal, etc) for product specific matters Accountable for the leadership of each vaccine’s cross-functional global matrix teams (GSC Product Strategy Leadership Teams - PSLT) Each PSLT is composed of senior representatives of all functions involved in the manufacturing, supply and life cycle management of the vaccines in the given portfolio: Site VPs/Directors, Global Supply Chain Director, Technical Life Cycle Management Director, Global Regulatory Affair Director, Global Product Quality Lead, Global Commercial Lead and Vaccine Finance Lead For all the vaccines in the given portfolio, each PSLT is responsible for: Managing the overall manufacturing and supply complexity, identifying the challenges and the responses as well as the opportunities and implementation routes Improving the overall performance through the reduction of production lead times and costs Rationalizing of the GSC product -life cycle management through the minimization of the number of change requests and the prioritization of essential over non-essential projects Overseeing and advising governing bodies and GSC/Quality forums on product specific matters Managing the major crisis situations & risks with, where applicable, the creation of a dedicated issue management team Basic Qualifications: University degree (Master) Scientific, Economic, Finance, Engineering 10 to 15 years in manufacturing, supply and control of human vaccines Strong business acumen Good understanding of the vaccine development, production (incl. testing and release) and supply constraints and environment (including competition) Ability to engage, influence and lead people from different areas of expertise including most senior colleagues Ability to help people see the big picture with complementary perspectives across different disciplines Strong analytical skills Information search capabilities Capability to act as a “single voice” Excellent written and spoken English, other languages are an asset Preferred Qualifications: If you have the following characteristics, it would be a plus: MBA Business Administration Ability to work effectively in a matrix organization across geographies and cultures, multi-cultural awareness Ability to drive change Ability to provide strategic advice as well as operational solutions Excellent organizational skills to oversee the coordination of projects *LI-GSK If you have a disability and require assistance during the course of the selection process, you will have the opportunity to let us know what specific assistance you require in order to make suitable arrangements. Why GSK? Uniting science, technology and talent to get ahead of disease together. GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. We prevent and treat disease with vaccines, specialty and general medicines. We focus on the science of the immune system and the use of new platform and data technologies, investing in four core therapeutic areas (infectious diseases, HIV, respiratory/ immunology and oncology). Our success absolutely depends on our people. While getting ahead of disease together is about our ambition for patients and shareholders, it’s also about making GSK a place where people can thrive. We want GSK to be a place where people feel inspired, encouraged and challenged to be the best they can be. A place where they can be themselves – feeling welcome, valued, and included. Where they can keep growing and look after their wellbeing. So, if you share our ambition, join us at this exciting moment in our journey to get Ahead Together. Important notice to Employment businesses/ Agencies GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK. GSK shall therefore not be liable for any fees arising from such actions or any fees arising from any referrals by employment businesses/agencies in respect of the vacancies posted on this site.